908 Devices (MASS)
(Delayed Data from NSDQ)
$5.67 USD
+0.11 (1.98%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $5.67 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
F Value B Growth D Momentum D VGM
Price, Consensus and EPS Surprise
MASS 5.67 +0.11(1.98%)
Will MASS be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for MASS based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for MASS
IQVIA Holdings (IQV) Reports Next Week: Wall Street Expects Earnings Growth
Intuitive Surgical, Inc. (ISRG) Q1 Earnings and Revenues Top Estimates
MASS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Nevro (NVRO) Reports Q4 Loss, Tops Revenue Estimates
908 Devices Inc. (MASS) Upgraded to Buy: What Does It Mean for the Stock?
How Much Upside is Left in 908 Devices Inc. (MASS)? Wall Street Analysts Think 100.39%
Other News for MASS
908 Devices to Report First Quarter 2024 Financial Results on April 30, 2024
Masivo Silver Expands Private Placement Offer
908 Devices: Rare Early-Stage Bioprocess Investment Opportunity
Masivo Silver Ramps Up Drilling Amidst Funding Efforts
3 Stocks Under $10 That Wall Street Sees More Than 100% Upside This Year